WCN24-1077 NOVEL BIOMARKERS AND PREDICTION OF KIDNEY DISEASE PROGRESSION IN AUSTRALIAN FIRST NATION PEOPLE WITH AND WITHOUT DIABETES: THE eGFR STUDY

Bibliographic Details
Published in:	Kidney International Reports
Main Authors:	Richard MacIsaac, Elizabeth Barr, Federica Barzi, Phillip Mills, Maria Nickels, Sian Graham, Varuni Obeyesekere, Wendy Hoy, Graham Jones, Paul Lawton, Alex Brown, Mark Thomas, Ashim Sinha, Alan Cass, Jaquelyne Hughes, Louise Maple-Brown
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924003267

Similar Items

Cardiometabolic Biomarkers and Prediction of Kidney Disease Progression: The eGFR Cohort Study
by: Elizabeth L. M. Barr, et al.
Published: (2025-08-01)

WCN25-405 eGFR Trajectories in Iraqi Cancer Patients at First Presentation
by: Ala Ali, et al.
Published: (2025-02-01)

To analyse the correlation between UAER and eGFR and the risk factors for reducing eGFR in patients with type 2 diabetes
by: Haihui Li, et al.
Published: (2024-10-01)

Assessing the Association between Serum Ferritin, Transferrin Saturation, and C-Reactive Protein in Northern Territory Indigenous Australian Patients with High Serum Ferritin on Maintenance Haemodialysis
by: Sandawana William Majoni, et al.
Published: (2017-01-01)

WCN25-2085 COST-EFFECTIVENESS ANALYSIS OF EMPAGLIFLOZIN FOR CHRONIC KIDNEY DISEASE BASED ON eGFR- AND ALBUMINURIA-BASED SUBGROUPS
by: Motoki Odawara, et al.
Published: (2025-02-01)

WCN25-2491 COMPARATIVE EVALUATION OF eGFR EQUATIONS FOR RENAL FUNCTION ASSESSMENT IN PREGNANT WOMEN: A CROSS-SECTIONAL STUDY IN VIETNAM
by: Hoang Nguyen Huy Ho, et al.
Published: (2025-02-01)

WCN25-629 LONG-TERM RISK OF ESKD IN KIDNEY DONORS WITH DIABETES MELLITUS USING eGFR AT 6 MONTHS POST-DONATION
by: Lovy Gaur, et al.
Published: (2025-02-01)

Vasodilator effects of cromakalim and HA 1077 in diabetic rat aorta
by: Tugba Gurpinar, et al.
Published: (2012-03-01)

eGFR slope as predictor of mortality in heart failure patients
by: Sofie Verstreken, et al.
Published: (2025-04-01)

New eGFR equations: Implications for cardiologists and racial inequities
by: Nali Gillespie, et al.
Published: (2023-03-01)

Estimation of eGFR and Albuminuria in Egyptian Patients with Hepatic Steatosis
by: Atef Abo ElFotouh Ibrahim, et al.
Published: (2025-12-01)

Evaluation of race-free eGFR equations in individuals of different ethnicity
by: De-Wei An, et al.
Published: (2025-12-01)

Should Cystatin C eGFR Become Routine Clinical Practice?
by: Sebastian Spencer, et al.
Published: (2023-07-01)

Association of neutrophil-to-lymphocyte ratio and microalbuminuria in patients with normal eGFR
by: Kutlugun Aysun Aybal, et al.
Published: (2018-03-01)

Combined Use of Serum Uromodulin and eGFR to Estimate Mortality Risk
by: Babak Yazdani, et al.
Published: (2021-09-01)

Association between Maternal Midterm eGFR and Newborn Birth Weight
by: Akiko Sankoda, et al.
Published: (2026-03-01)

Cystatin C Confirms the Canagliflozin eGFR Slope Benefit in CANPIONE
by: Satoshi Miyamoto, et al.
Published: (2026-05-01)

Low eGFR is associated with dysexecutive and amnestic mild cognitive impairment
by: Andrea R. Zammit, et al.
Published: (2015-06-01)

WCN24-1427 Epidemiology of kidney disease in patients without health insurance in a Latin American city. Who develop accelerated deterioration of eGFR
by: Diego Argudo, et al.
Published: (2024-04-01)

WCN25-1898 IMPLICATIONS OF PROTEINURIA REMISSION ON ESTIMATED GLOMERULAR FILTRATION RATE (eGFR) TRAJECTORY IN PATIENTS (Pts) WITH IgA NEPHROPATHY (IgAN) IN PROTECT
by: Bruce Hendry, et al.
Published: (2025-02-01)

Feasibility of replacing 99mTc‐DTPA GFR measurements with eGFR from cystatin C in individuals with spinal cord injuries
by: Tatiana Kristensen, et al.
Published: (2025-05-01)

Measurement of glomerular filtration rate in patients undergoing renal surgery for cancer: eGFR vs mGFR in the era of precision medicine
by: Francesco Trevisani, et al.
Published: (2024-04-01)

P1077: HODGKIN LYMPHOMA IN PATIENTS WITH HIV: NATIONAL RETROSPECTIVE MULTICENTER STUDY
by: A. Chekalov, et al.
Published: (2022-06-01)

WCN24-1774 eGFR DECLINE IN PATIENTS WITH IgAN TREATED WITH NEFECON OR PLACEBO: RESULTS FROM THE 2-YEAR NefIgArd PHASE 3 TRIAL
by: Richard Lafayette, et al.
Published: (2024-04-01)

Association of eGFR-Related Loci Identified by GWAS with Incident CKD and ESRD.
by: Carsten A Böger, et al.
Published: (2011-09-01)

Variability in Reporting eGFR at Dialysis Initiation in Canada: A Research Letter
by: Michael Chiu, et al.
Published: (2023-09-01)

Impact of ‘Black Race’ Coefficient in eGFR on Our Community and Medical Education
by: Shibani Kanungo, et al.
Published: (2023-07-01)

Clinicopathological features of fast eGFR decliners among patients with diabetic nephropathy
by: Miho Shimizu, et al.
Published: (2020-04-01)

Evaluating Long-Term Outcomes Across eGFR Equations in Older Adults
by: Elisa K. Bongetti, et al.
Published: (2026-06-01)

Variability of urinary albumin to creatinine ratio and eGFR are independently associated with eGFR slope in Japanese with type 2 diabetes: a three-year, single-center, retrospective cohort study
by: Takaaki Matsuda, et al.
Published: (2024-08-01)

WCN25-3835 WHICH GFR FORMULA IS MOST ACCURATE IN INDIAN CIRRHOTIC POPULATION?
by: Smita Divyaveer, et al.
Published: (2025-02-01)

WCN24-1597 A PROSPECTIVE STUDY TO ANALYSE THE ACCURACY OF ESTIMATED GFR EQUATIONS AS COMPARED TO MEASURED GFR BY IOHEXOL CLEARANCE IN PATIENTS WITH LIVER CIRRHOSIS
by: Smita Divyaveer, et al.
Published: (2024-04-01)

WCN24-1644 CONSEQUENCES of EXPOSURE to FAMINE EXPOSURE on the eGFR DECLINE and LATER LIFE CKD RISK AMONG SURVIVORS of the GREAT CHINESE FAMINE: a RETROSPECTIVE STUDY
by: Ye Zhu, et al.
Published: (2024-04-01)

Bone health in young adults with type 1 diabetes and progressive eGFR decline
by: Funmbi Babalola, et al.
Published: (2024-05-01)

Estimation of Glomerular Filtration Rate (eGFR): Implicit Racism in Medicine and Medical Education
by: Amy R. Lorber, et al.
Published: (2023-09-01)

Differential correlation between time in range and eGFR or albuminuria in type 2 diabetes
by: Xuguang Jin, et al.
Published: (2023-05-01)

Renal Function Trajectories in Patients with Prior Improved eGFR Slopes and Risk of Death.
by: Yan Xie, et al.
Published: (2016-01-01)

Mapping eGFR loci to the renal transcriptome and phenome in the VA Million Veteran Program
by: Jacklyn N. Hellwege, et al.
Published: (2019-08-01)

Recording blood pressure and eGFR in primary care after the Belgrade screening study
by: Visnja Lezaic, et al.
Published: (2018-10-01)

Prevalence of Hyperkalemia in a Contemporary European Cohort According to EKFC eGFR Categories
by: Priscila Villalvazo, et al.
Published: (2026-04-01)